General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Med-IQ (SIGNIFICANT), Kaneka(MODEST) RESEARCH/RESEARCH GRANTS: DCRI(NONE), Novartis Corporation(NONE), Novartis Corporation(NONE), AstraZeneca(SIGNIFICANT), Amgen Inc.(NONE)

View Full Disclosure